These results revealed that after COL1A1 silencing, the expression levels of ɑ-SMA and FAP were decreased, while the expression levels of E-cadherin and Cav-1 were increased, indicating that COL1A1 silencing may inhibit fibroblast activation and tumor metastasis. The gene discussed is CDH1; the disease is neoplasm.